Evidence map›Paper›PMID 39900436›Full record

ArticleLife science alliance2025

Assessment of PRMT6-dependent alternative splicing in pluripotent and differentiating NT2/D1 cells.

Matthias Eudenbach, Jonas Busam, Caroline Bouchard, Oliver Rossbach, Kathi Zarnack, Uta-Maria Bauer

Abstract read
In one paragraph

Article in Life science alliance, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Matthias EudenbachInstitute for Molecular Biology and Tumor Research (IMT), Philipps-University Marburg, Marburg, Germany.
Jonas BusamBuchmann Institute for Molecular Life Sciences (BMLS) and Institute of Molecular Biosciences, Goethe University Frankfurt, Frankfurt, Germany.
Caroline BouchardInstitute for Molecular Biology and Tumor Research (IMT), Philipps-University Marburg, Marburg, Germany.
Oliver RossbachInstitute of Biochemistry, Faculty of Biology and Chemistry (FB08), Justus-Liebig-University of Giessen, Giessen, Germany.
Kathi ZarnackBuchmann Institute for Molecular Life Sciences (BMLS) and Institute of Molecular Biosciences, Goethe University Frankfurt, Frankfurt, Germany.ORCID 0000-0003-3527-3378
Uta-Maria BauerInstitute for Molecular Biology and Tumor Research (IMT), Philipps-University Marburg, Marburg, Germany bauer@imt.uni-marburg.de.ORCID 0000-0003-1344-9117

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Protein arginine methyltransferase 6 (PRMT6) is a well-characterized epigenetic regulator that methylates histone H3 at arginine 2 (H3R2me2a) in both promoter and enhancer regions, thereby modulating transcriptional initiation. We report here that PRMT6 also regulates gene expression at the post-transcriptional level in the neural pluripotent state and during neuronal differentiation of NT2/D1 cells. PRMT6 knockout causes widespread alternative splicing changes in NT2/D1 cells, most frequently cassette exon alterations. Most of the PRMT6-dependent splicing targets are not transcriptionally affected by the enzyme and regulated in an H3R2me2a-independent manner. However, for a small subset of splicing events, the PRMT6-mediated deposition of H3R2me2a overlaps with the splice site, suggesting a potential dual function in both transcriptional and co-/post-transcriptional regulation. The splicing targets of PRMT6 include ribosomal proteins, splicing factors, and chromatin-modifying enzymes such as PRMT4, DNMT3B, and ASH2L, some of which are associated with differentiation decisions. Taken together, our results in NT2/D1 cells show that PRMT6 exerts predominantly H3R2me2a-independent functions in RNA splicing, which may contribute to pluripotency and neuronal identity.

Indexed as

Alternative SplicingCell DifferentiationNuclear ProteinsPluripotent Stem CellsProtein-Arginine N-MethyltransferasesAnimalsCell LineGene Expression RegulationHistonesHumansMiceNeuronsHistonesNuclear ProteinsPRMT6 protein, humanProtein-Arginine N-Methyltransferases

Identifiers

PMID39900436
PMCPMC11791029

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.